BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4310150)

  • 21. Response of chick oviduct adenyl cyclase to steroid hormones.
    Kissel JH; Rosenfeld MG; Chase LR; O'Malley BW
    Endocrinology; 1970 May; 86(5):1019-23. PubMed ID: 4314065
    [No Abstract]   [Full Text] [Related]  

  • 22. Platelet phosphorylase activity in the presence of activators and inhibitors of aggregation.
    Deisseroth A; Wolfe SM; Shulman NR
    Biochem Biophys Res Commun; 1970 Jul; 40(1):551-7. PubMed ID: 4318585
    [No Abstract]   [Full Text] [Related]  

  • 23. The effects of ATP on platelets: evidence against the central role of released ADP in primary aggregation.
    Macfarlane DE; Mills DC
    Blood; 1975 Sep; 46(3):309-20. PubMed ID: 167888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostacyclin stimulation of the activation of blood coagulation factor X by platelets.
    Dutta-Roy AK; Ray TK; Sinha AK
    Science; 1986 Jan; 231(4736):385-8. PubMed ID: 3001935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human platelet secretion and aggregation induced by calcium ionophores. Inhibition by PGE1 and dibutyryl cyclic AMP.
    Feinstein MB; Fraser C
    J Gen Physiol; 1975 Nov; 66(5):561-81. PubMed ID: 172596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substances that increase the cyclic AMP content prevent platelet aggregation and the concurrent release of pharmacologically active substances evoked by arachidonic acid.
    Vargaftig BB; Chignard M
    Agents Actions; 1975 May; 5(2):137-44. PubMed ID: 51579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets.
    Best LC; Martin TJ; Russell RG; Preston FE
    Nature; 1977 Jun; 267(5614):850-2. PubMed ID: 197414
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of renal adenosine 3',5'-monophosphate in the control of erythropoietin production.
    Rodgers GM; Fisher JW; George WJ
    Am J Med; 1975 Jan; 58(1):31-8. PubMed ID: 163577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of platelet cyclic nucleotide content by PGE1 and the prostaglandin endoperoxide PGG2.
    Miller OV; Gorman RR
    J Cyclic Nucleotide Res; 1976; 2(2):79-87. PubMed ID: 177467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initial biochemical responses of platelets to stimulation.
    Mills DC
    Ciba Found Symp; 1975; 35():153-73. PubMed ID: 179766
    [No Abstract]   [Full Text] [Related]  

  • 31. Triene prostaglandins: prostaglandin D3 and icosapentaenoic acid as potential antithrombotic substances.
    Whitaker MO; Wyche A; Fitzpatrick F; Sprecher H; Needleman P
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5919-23. PubMed ID: 230492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mechanism of action of parathyroid hormone: lack of evidence for the mediation by cyclic adenosine 3', 5'-monophosphate of parathyroid hormone-stiulated phosphaturia.
    Sallis JD
    J Endocrinol; 1970 Feb; 46(2):185-90. PubMed ID: 4321633
    [No Abstract]   [Full Text] [Related]  

  • 33. Platelet physiology and abnormalities of platelet function (first of two parts).
    Weiss HJ
    N Engl J Med; 1975 Sep; 293(11):531-41. PubMed ID: 168489
    [No Abstract]   [Full Text] [Related]  

  • 34. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
    Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
    J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandin d2 as a potential antithrombotic agent.
    Nishizawa EE; Miller WL; Gorman RR; Bundy GL; Svensson J; Hamberg M
    Prostaglandins; 1975 Jan; 9(1):109-21. PubMed ID: 806102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of prostaglandins, derivatives of cyclic 3':5'-AMP, theophylline, cholinergic agents and colchicine on clot retraction in dilute platelet-rich plasma and gel-separated platelet test systems.
    Moake JL; Cimo PL; Widmer K; Peterson DM; Gum JR
    Thromb Haemost; 1977 Aug; 38(2):420-8. PubMed ID: 202038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positive inotropic effects of dibutyryl cyclic adenosine 3',5'-monophosphate.
    Skelton CL; Levey GS; Epstein SE
    Circ Res; 1970 Jan; 26(1):35-43. PubMed ID: 4312000
    [No Abstract]   [Full Text] [Related]  

  • 38. Activation of monkey spermatozoal adenyl cyclase by thyroxine and triiodothyronine.
    Casillas ER; Hoskins DD
    Biochem Biophys Res Commun; 1970 Jul; 40(2):255-62. PubMed ID: 4319823
    [No Abstract]   [Full Text] [Related]  

  • 39. Platelet disaggregation and refractoriness to ADP.
    Holmsen H; Rozenberg MC
    Acta Med Scand Suppl; 1971; 525():113-6. PubMed ID: 4260812
    [No Abstract]   [Full Text] [Related]  

  • 40. Adenyl cyclase activity in rat pineal gland: effects of chronic denervation and norepinephrine.
    Weiss B; Costa E
    Science; 1967 Jun; 156(3783):1750-2. PubMed ID: 4305967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.